During the past decade, General Hospital Zadar conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Zadar" #1 sponsor was "Pfizer" with 3 trials, followed by "Shire" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "General Hospital Zadar" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Zadar" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "General Hospital Zadar" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "University Hospital of Split" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Zadar" are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (4 trials), "Atrial Fibrillation" (2 trials), "Abdominal Surgery" (1 trials) and "Anesthesia Recovery Period" (1 trials). Many other conditions were trialed in "General Hospital Zadar" in a lesser frequency.

Most popular intervention types in "General Hospital Zadar" are "Drug" (17 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (4 trials), "Edoxaban" (2 trials), "Ontamalimab" (2 trials) and "1.25 g PA21 (250 mg iron)" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Zadar" are 19 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Zadar". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in General Hospital Zadar, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Zadar, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".